Tags

Type your tag names separated by a space and hit enter

Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome.
Best Pract Res Clin Obstet Gynaecol. 2004 Oct; 18(5):803-12.BP

Abstract

Metabolic abnormalities and obesity have long been associated with the development of cardiovascular disease in the general population. These same features are also associated with polycystic ovary syndrome (PCOS). An increased prevalence of hypertension, dyslipidaemia, obesity and hyperinsulinaemia, as well as changes in coagulation and blood vessel function, provide an explanation as to why women with PCOS are at an increased risk of developing cardiovascular disease over the long term.

Authors+Show Affiliations

Cattrall FR
Department of Obstetrics and Gynaecology, Monash University, Level 5, Monash Medical Centre, 246 Clayton Road, Clayton, Melbourne 3168, Australia. fleurcat@hotmail.com
Healy DL
No affiliation info available

MeSH

Cardiovascular DiseasesFemaleHumansMetabolic SyndromeNeoplasmsObesityPolycystic Ovary SyndromeRisk Factors

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

15380148

Citation

Cattrall, Fleur R., and David L. Healy. "Long-term Metabolic, Cardiovascular and Neoplastic Risks With Polycystic Ovary Syndrome." Best Practice & Research. Clinical Obstetrics & Gynaecology, vol. 18, no. 5, 2004, pp. 803-12.
Cattrall FR, Healy DL. Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18(5):803-12.
Cattrall, F. R., & Healy, D. L. (2004). Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome. Best Practice & Research. Clinical Obstetrics & Gynaecology, 18(5), 803-12.
Cattrall FR, Healy DL. Long-term Metabolic, Cardiovascular and Neoplastic Risks With Polycystic Ovary Syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18(5):803-12. PubMed PMID: 15380148.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome. AU - Cattrall,Fleur R, AU - Healy,David L, PY - 2004/9/24/pubmed PY - 2005/2/4/medline PY - 2004/9/24/entrez SP - 803 EP - 12 JF - Best practice & research. Clinical obstetrics & gynaecology JO - Best Pract Res Clin Obstet Gynaecol VL - 18 IS - 5 N2 - Metabolic abnormalities and obesity have long been associated with the development of cardiovascular disease in the general population. These same features are also associated with polycystic ovary syndrome (PCOS). An increased prevalence of hypertension, dyslipidaemia, obesity and hyperinsulinaemia, as well as changes in coagulation and blood vessel function, provide an explanation as to why women with PCOS are at an increased risk of developing cardiovascular disease over the long term. SN - 1521-6934 UR - https://www.unboundmedicine.com/medline/citation/15380148/Long_term_metabolic_cardiovascular_and_neoplastic_risks_with_polycystic_ovary_syndrome_ DB - PRIME DP - Unbound Medicine ER -